Bill Ringo is listed as a director on 1 SEC Form D filing by 1 issuer in Mar 2011: ALVINE PHARMACEUTICALS INC (San Carlos, CA — other health care — 2011; $26.5M reported sold to 18 investors).
What this means One deal on file with the SEC, filed Mar 2011. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Abhay Joshi (1 shared filing), Chaitan Khosla (1 shared filing), David Southern (1 shared filing), Gaurav Aggarawal (1 shared filing), Ilan Zipkin (1 shared filing) and 3 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Bill. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, VT, WA, WI, WV, WY) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 1 public filing for Bill Ringo and found 1 difference: Offering amount changed between filings.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.